Dr. Jeah Jung is a Professor in the Department of Health Administration and Policy. Jung’s research analyzes health policy issues using approaches to infer causal relations from observational data. Jung’s focus has been on provider incentives, prescription drug policies, Medicare Advantage, and health disparities. Jung has been the Principal Investigator of several R01 grants from the National Institute on Aging (NIA). Her work appears in high-quality health economics or health services research journals, including Health Services Research, Health Economics, and Journal of Health Economics. She currently serves on an NIH study section as a standing member, and she teaches the Centers for Medicare and Medicaid Services workshop on how to Medicare Part D data for health research. Before coming to Mason, Jung was a faculty member in the Department of Health Policy and Administration at the Pennsylvania State University.
Jung, J., Carlin, C., Feldman, R., Measuring Resource Use in Medicare Advantage using Encounter Data. Health Services Research, September 2021. doi: 10.1111/1475-6773.13879. Online ahead of print.
Park, S., Jung, J., Burke, R., Larson, E., Low-value care in Traditional Medicare and Medicare Advantage, 2006-2015. JAMA Network Open, 2021;4(3):e211762. doi:10.1001/jamanetworkopen.2021.1762
Jung, J. Feldman, R., Kalidindi. Y., Riley, T. Association of Direct Anti-viral Agents with After-Treatment Medical Costs in Medicare. JAMA Network Open. 2020;3(6):e208081.
Jung, J., Feldman, R., Kalidindi, Y., The Impact of Integration on Outpatient Chemotherapy Service Use and Spending in Medicare. Health Economics, 2019, 28:4, 517-528
Wu, B., Jung, J., Kim, H., Polsky, D. Entry Regulation and the Effect of Public Reporting: Evidence from Medicare Home Health Compare. Health Economics, 2019, 28:4, 492-516
Jung, J., Feldman, R., Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D. Health Services Research, 2018, 53:6, 4371-4380
Jung, J., Xu, W., Kalidindi, Y. The Impact of the 340B Drug Pricing Program on Care Site and Spending in Medicare. Health Services Research, 2018, 53(5), 3528-3548.
Jung, J., Feldman, R., McBean, M., The Price Elasticity of Specialty Drug Use: Evidence from Medicare Part D Enrollees with Cancer. Forum for Health Economics and Policy, 2017, 20:2
Xu, W., Jung, J., Socio-economic Differences in Overuse of Cancer Screening Tests and Distributional Effects in Medicare. Health Services Research, 2017;52(5):1772-1793.
Jung, JK, Wu, B., Kim, H., Polsky, D., The Effect of Publicized Quality Information on Home Health Agency Choice. Medical Care Research and Review. 2016 Dec; 73(6):703-723.
Jung, JK, Feldman, R., Cheong, C., Du, P., Leslie, D. Coverage of Hepatitis C Drugs in Medicare Part D. American Journal of Managed Care. 2016;22(5 Spec Issue No. 6):SP220-SP226
Jung, K., Polsky, D., Competition and Quality in Home Health Care Markets. Health Economics, 2014 Mar; 23(3): 298-313
Jung, K., Feldman, R., McBean, M., Nonlinear Pricing in Drug Benefits and Medication Utilization: The Case of Statin Compliance in Medicare Part D. Health Services Research 2014 June 49(3): 910-28
Jung, K., Feldman, R., Scanlon, D., Where Would You Go for Your Next Hospitalization? Journal of Health Economics, 2011;30; pp. 832– 841
Jung, K., Incentives for Voluntary Disclosure of Quality Information in HMO markets. Journal of Risk and Insurance,2010. 77:1; pp. 183-210
“Resource Use and Quality of Care in Medicare Advantage”, National Institute on Aging (NIA), Award number R01AG069352-01A1, September 2020-June 2024, $2,410,884 (Role: Principal Investigator)
“Use of New Hepatitis C Drugs and Patients’ Health Outcomes in Medicare”, National Institute on Aging (NIA), Award number R01AG055636-01A1, December 2017-November 2021, $1,453,289 (Role: Principal Investigator)
“Use of New Hepatitis C Drugs and Patients’ Health Outcomes in Medicare: Disparities in Use of New Hepatitis C Drugs in Medicare,” National Institute on Aging (NIA), R01 Administrative Supplement, December 2018 – November 2019, $70,588 (Role: Principal Investigator)
“Benefit Generosity, Specialty Drug Use and Other Health Service use in Medicare”, National Institute on Aging (NIA), Award number R01AG047934-01, September 2014-January 2019, $790,753 (Role: Principal Investigator)
“Public Reporting and Market Area Exit Decisions by Home Health Agencies”, National Institute on Aging (NIA), Award number R01AG035098-01, May 2010-April 2014, $163,713 (Role: Principal Investigator)
Honors and Awards
- Second-place Winner, Paper Competition by Patient Access Network (PAN) Foundation and American Journal of Managed Care, 2016
- Fran and Holly Soitsman Faculty Development Endowment, College of Health Human Development, Penn State University, 2012
- Delta Omega Phi, The Honorary Public Health Society, University of Minnesota, 2007
- Editorial board member, PharmacoEconomics 2018 - present
- Editorial board member, Korean Journal of Health Economics and Policy 2016 - present
- Standing Member, NIH Study section, Organization and Delivery of Health Services, July 2019 – present
- Ad-hoc reviewer, NIH Study section, 2016-2018
- Member, Strategic Planning Committee, Department of Health Policy and Administration, Pennsylvania State University (2020-2021)
- Chair, Faculty Development Committee, Department of Health Policy and Administration, Pennsylvania State University (2017-2020)
- Member/Chair, Promotion and Tenure Committee, Department of Health Policy and Administration, Pennsylvania State University (2014-2021)
- Member, PhD Program Committee, Department of Health Policy and Administration, Pennsylvania State University (2007-2013)
- Research Data Assistance Center (ResDAC), University of Minnesota, 9/1/10 - present
- Developing and Leading Annual Workshop on How to Use Medicare Part D Data for Health Research
- Member, AcademyHealth, https://academyhealth.org/
- Member, International Health Economics Association, https://www.healtheconomics.org/
- Member, American Society of Health Economists, https://www.ashecon.org/
- PhD, Health Policy/Economics, University of Minnesota
- MPH, Health Policy, Seoul National University (Korea)
- BS, Pharmacy, Seoul National University (Korea)